BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28425245)

  • 1. Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients.
    Karacaoğlan V; Ada AO; Bilgen S; Çetinkaya GT; Soydaş E; Kunak CS; Alpar SM; Gülhan M; Işcan M
    Turk J Med Sci; 2017 Apr; 47(2):554-562. PubMed ID: 28425245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the TP53 and CYP2E1*5B gene polymorphisms and non-small cell lung cancer.
    Ada AO; Bilgen S; Karacaoglan V; Kunak CS; Soydas E; Alpar S; Gulhan M; Iscan M
    Arh Hig Rada Toksikol; 2016 Dec; 67(4):311-316. PubMed ID: 28033105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
    Wu G; Jiang B; Liu X; Shen Y; Yang S
    Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
    Lu C; Spitz MR; Zhao H; Dong Q; Truong M; Chang JY; Blumenschein GR; Hong WK; Wu X
    Cancer; 2006 Jan; 106(2):441-7. PubMed ID: 16342067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients.
    Ada AO; C Kunak S; Hancer F; Bilgen S; Suzen SH; Alpar S; Gulhan M; Kurt B; Iscan M
    Neoplasma; 2010; 57(6):512-21. PubMed ID: 20845989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the genetic polymorphisms of phase I and II drug-metabolizing enzymes, as well as the outcome of chemotherapy in advanced non-small cell lung cancer].
    Li W; Yue W; Yang X; Zhang C; Wang Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):858-64. PubMed ID: 22104220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
    Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
    Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.
    Li W; Yue W; Zhang L; Zhao X; Ma L; Yang X; Zhang C; Wang Y; Gu M
    Lung; 2012 Feb; 190(1):91-8. PubMed ID: 22109568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
    Han JY; Lee GK; Jang DH; Lee SY; Lee JS
    Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer.
    Jia W; Sun JY; Jia KY; Liu XC
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and Interactive Effect of CYPs and GSTs Genetic Variants and Tobacco Smoking on the Risk of Non-Small Cell Lung Carcinoma.
    Pathak AK; Husain N; Kant S; Bala L
    Arch Med Res; 2021 Oct; 52(7):719-730. PubMed ID: 34092421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients.
    Nairuz T; Bushra YU; Kabir Y
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3809-3815. PubMed ID: 34967559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
    Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
    J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population.
    Xiao HL; Yang ZT; Han F; Wei HX
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
    Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.
    Tan C; Xu HY; Zhang CY; Zhang H; Chen CM; Zhang WM; Sun XY; Jin YT
    Arch Med Res; 2011 Nov; 42(8):669-76. PubMed ID: 22154617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer.
    Goto I; Yoneda S; Yamamoto M; Kawajiri K
    Cancer Res; 1996 Aug; 56(16):3725-30. PubMed ID: 8706015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.